András P.
- Country
- Hungary
- Department
- Ophtalmology
Research Overview
- A Randomized, Double-masked Study Comparing the Efficacy and Safety of AVT29 Versus High-Dose Aflibercept in Participants with Diabetic Macular Edema
- A Phase 3 Randomized Study Comparing the Efficacy of Vorolanib to Aflibercept in Participants with Diabetic Macular Edema
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
Data & Insights
Has run more than one trial at 641 of 1353 partner sites.
Specializations
Cardiovascular medicine
András József Papp is involved in clinical research centered on atherosclerotic cardiovascular disease, coronary artery disease, myocardial infarction, acute coronary syndrome, and heart failure, with additional interest in atrial fibrillation, hypertension, and dyslipidaemia.
- Preventive lipid management
- Heart failure and ventricular dysfunction
- Thromboembolic risk and stroke prevention
- Hypertrophic cardiomyopathy
His trial portfolio also includes interest in lipoprotein(a), hypertriglyceridaemia, and broader cardiometabolic risk.
Inflammatory bowel disease and gastroenterology
He contributes to studies in Crohn's disease, ulcerative colitis, and related digestive system diseases, reflecting a strong therapeutic focus on chronic intestinal inflammation and disease control.
- Moderate to severe Crohn's disease
- Ulcerative colitis
- Fistulizing perianal Crohn's disease
- Short bowel syndrome
The research landscape also includes colonic disease and gastroenteropancreatic neuroendocrine tumors.
Autoimmune, immunologic, and inflammatory disorders
His clinical trial activity extends across systemic lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, systemic sclerosis, myasthenia gravis, and immune thrombocytopenia, alongside other immune-mediated conditions.
- Systemic autoimmune disease
- Inflammatory arthritis
- Neuromuscular autoimmunity
- Complement- and antibody-mediated disorders
Additional areas include bullous pemphigoid, hereditary angioedema, and IgA nephropathy.
Metabolic, renal, and endocrine disease
He is engaged in trials addressing chronic kidney disease, proteinuria, type 2 diabetes, obesity, and metabolic dysfunction-associated steatohepatitis, with a focus on cardiometabolic and renal risk.
- Kidney disease and transplant-related complications
- Diabetes mellitus and microvascular complications
- Obesity and metabolic syndrome
- Lipid disorders
His research profile also includes familial hypercholesterolaemia and hypoparathyroidism.
Respiratory, neurologic, and ophthalmic therapeutics
His trial involvement covers chronic rhinosinusitis, bronchiectasis, idiopathic pulmonary fibrosis, migraine, epilepsy, Alzheimer's disease, and age-related macular degeneration, indicating a broad interest in multisystem chronic disease management.
- Airway and interstitial lung disease
- Headache and seizure disorders
- Neurocognitive disease
- Retinal and macular disease
Other areas include diabetic retinopathy, neurogenic orthostatic hypotension, and pulmonary arterial hypertension.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.